19th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200138741 | PHARMACEUTICAL COMPOSITION CONTAINING BROUSSOCHALCONE A AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE | 2020-05-07 |
20200138742 | OPHTHALMIC COMPOSITION CONTAINING CLATHRATED ANTIOXIDANT SUBSTANCE, AND USE THEREOF | 2020-05-07 |
20200138743 | COMPOSITIONS COMPRISING THYMOQUINONE AND OMEGA-3 FATTY ACIDS | 2020-05-07 |
20200138744 | METHODS OF TREATING PANCREATIC CANCER USING COENZYME Q10 | 2020-05-07 |
20200138745 | METHOD FOR PREVENTING, TREATING, OR AMELIORATING A MICROBIAL INFECTION | 2020-05-07 |
20200138746 | METHOD FOR PREVENTING, TREATING, OR AMELIORATING A MICROBIAL INFECTION | 2020-05-07 |
20200138747 | METHODS FOR TREATING ATHEROSCLEROSIS WITH GAMMA-KETOALDEHYDE SCAVENGERS | 2020-05-07 |
20200138748 | COMPOSITION AND METHOD FOR AIDING SLEEP | 2020-05-07 |
20200138749 | PHARMACEUTICAL COMPOSITION FOR VIRAL INFECTIONS | 2020-05-07 |
20200138750 | Use of Mustard Seed Oil (Allyl Isothiocyanate) to relieve headache pain | 2020-05-07 |
20200138751 | Biguanide Compositions and Methods of Treating Metabolic Disorders | 2020-05-07 |
20200138752 | 2-amino-N'-benzylideneacetohydrazides and Derivatives for the Management of CFTR Protein Mediated Diseases | 2020-05-07 |
20200138753 | CONTROLLING BIOFILMS WITH CYCLOPROPANATED FATTY ACIDS | 2020-05-07 |
20200138754 | ANTIMICROBIALS AND METHODS OF USE THEREOF | 2020-05-07 |
20200138755 | MIXTURE OF CARBOXYLIC ACIDS FOR TREATING PATIENTS WITH KIDNEY FAILURE | 2020-05-07 |
20200138756 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION | 2020-05-07 |
20200138757 | COMPOUNDED COMPOSITIONS AND METHODS FOR TREATING PAIN | 2020-05-07 |
20200138758 | FORMULATIONS FOR ADMINISTRATION OF EFLORNITHINE | 2020-05-07 |
20200138759 | PHARMACEUTICALLY ACCEPTABLE SALTS OF BETA-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF | 2020-05-07 |
20200138760 | New Therapy for Transthyretin-Associated Amyloidosis | 2020-05-07 |
20200138761 | COMPOSITIONS CONTAINING INOSITOL-STABILIZED ARGININE SILICATE COMPLEXES AND INOSITOL FOR IMPROVING COGNITIVE FUNCTION IN VIDEO GAMERS | 2020-05-07 |
20200138762 | MEDIUM CHAIN FATTY ACIDS FOR USE IN THE PREVENTION OR TREATMENT OF CARDIAC ENLARGEMENT AND/OR VALVULAR HEART DISEASE | 2020-05-07 |
20200138763 | METHODS FOR INCREASING ORAL OSTEOGENESIS USING LIPOXIN A4 (LXA4) AND ITS ANALOGS | 2020-05-07 |
20200138764 | METHODS AND DEVICES FOR ACTIVATING ADIPOSE TISSUE | 2020-05-07 |
20200138765 | CHLOROGENIC ACID COMPOSITION AND METHOD OF WEIGHT MANAGEMENT | 2020-05-07 |
20200138766 | CCL5 INHIBITORS | 2020-05-07 |
20200138767 | HYDROXYCITRIC ACID COMPOUNDS AND CAPSULE LIQUID DELIVERY | 2020-05-07 |
20200138768 | METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT | 2020-05-07 |
20200138769 | Pharmaceutical composition | 2020-05-07 |
20200138770 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2020-05-07 |
20200138771 | ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS | 2020-05-07 |
20200138772 | STABILIZED FORMULATIONS OF CANNABINOID COMPOSITIONS | 2020-05-07 |
20200138774 | LIQUID CARBON DIOXIDE BOTANICAL EXTRACTION SYSTEM | 2020-05-07 |
20200138775 | OZONIDES FOR TREATING OR PREVENTING VIRUS INFECTIONS | 2020-05-07 |
20200138776 | COMPOSITION FOR USE IN THE TREATMENT OF ENDOMETRIOSIS AND SYMPTOMS ASSOCIATED WITH ENDOMETRIOSIS | 2020-05-07 |
20200138777 | COMPOUNDS AND METHODS OF TREATING BACTERIAL INFECTIONS | 2020-05-07 |
20200138778 | GLYCOPYRROLATE SALTS | 2020-05-07 |
20200138779 | FABP4 AS A THERAPEUTIC TARGET IN SKIN DISEASES | 2020-05-07 |
20200138780 | METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C | 2020-05-07 |
20200138781 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS | 2020-05-07 |
20200138782 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER | 2020-05-07 |
20200138783 | TIME RELEASE SLEEP AID SYSTEM | 2020-05-07 |
20200138784 | PROCESSES USEFUL FOR THE PREPARATION OF 1-[3-(4-BROMO-2-METHYL-2H-PYRAZOL-3-YL)-4-METHOXY-PHENYL]-3-(2,4-DIFLUORO- -PHENYL)-UREA AND CRYSTALLINE FORMS RELATED THERETO | 2020-05-07 |
20200138785 | USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS | 2020-05-07 |
20200138786 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | 2020-05-07 |
20200138787 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | 2020-05-07 |
20200138788 | DEXMEDETOMIDINE INJECTION PREMIX FORMULATION IN READY TO USE (RTU) BAGS | 2020-05-07 |
20200138789 | CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | 2020-05-07 |
20200138790 | TRIAZOLONE COMPOUNDS AND USES THEREOF | 2020-05-07 |
20200138791 | METHODS OF INHIBITING LEUKOTRIENE A4 HYDROLASE | 2020-05-07 |
20200138792 | PHARMACEUTICAL COMBINATIONS OF ZONISAMIDE AND PRAMIPEXOLE, AND RELATED METHODS, FOR TREATING SYNUCLEINOPATHIES | 2020-05-07 |
20200138793 | METHODS OF TREATING BLADDER CANCER | 2020-05-07 |
20200138794 | NOVEL PARASITE THERAPY | 2020-05-07 |
20200138795 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE | 2020-05-07 |
20200138796 | COMPOSITIONS AND METHODS FOR DRUG SENSITIZATION OF PARASITES | 2020-05-07 |
20200138797 | Spirocyclic Indolines as IL-17 Modulators | 2020-05-07 |
20200138798 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | 2020-05-07 |
20200138799 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY FIBROSIS | 2020-05-07 |
20200138800 | METHOD FOR TREATING MOVEMENT DISORDERS WITH BEFIRADOL | 2020-05-07 |
20200138801 | COMPOSITION AND METHOD FOR PREVENTING OR DELAYING ONSET OF MYOPIA COMPRISING ATROPINE | 2020-05-07 |
20200138802 | Aggressive Lipid Lowering Therapy in Coronary Artery Disease | 2020-05-07 |
20200138803 | PHARMACEUTICAL COMPOSITION COMPRISING QUINOLINE DERIVATIVE OR SALT THEREOF | 2020-05-07 |
20200138804 | METHODS FOR TREATING CANCER | 2020-05-07 |
20200138806 | Nutlin-3a for Treatment of Proliferative Vitreoretinopathy | 2020-05-07 |
20200138807 | TYROSINE KINASE INHIBITORS REGENERATE NON-CANCEROUS TISSUE AFTER CANCER THERAPY | 2020-05-07 |
20200138808 | NEW HETEROARYL AMIDE DERIVATIVES AS SELECTIVE INHIBITORS OF HISTONE DEACETYLASES 1 AND/OR 2 (HDAC1-2) | 2020-05-07 |
20200138809 | FGFR2 INHIBITORS FOR THE TREATMENT OF CHOLANGIOCARCINOMA | 2020-05-07 |
20200138810 | TREATMENT OF ANEURYSMS | 2020-05-07 |
20200138811 | Chemical Compounds | 2020-05-07 |
20200138812 | LIVER X RECEPTOR MODULATORS | 2020-05-07 |
20200138813 | COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE | 2020-05-07 |
20200138814 | COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE | 2020-05-07 |
20200138815 | METHODS AND MEDICAL USES | 2020-05-07 |
20200138816 | Inhibitors of Multidrug Resistance Transporter P-Glycoprotein | 2020-05-07 |
20200138817 | PHARMACEUTICAL COMPOSITIONS COMPRISING AFATINIB | 2020-05-07 |
20200138818 | METHODS OF TREATING PAIN AND/OR INFLAMMATORY DISORDERS USING LAPATINIB | 2020-05-07 |
20200138819 | GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR THE TREATMENT OF ENDOMETRIOSIS | 2020-05-07 |
20200138820 | ORGANIC COMPOUNDS | 2020-05-07 |
20200138821 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS | 2020-05-07 |
20200138822 | TOPICAL COMPOSITIONS COMPRISING PENTOXIFYLLINE AND METHODS OF TREATMENT USING THE SAME | 2020-05-07 |
20200138823 | DRUG COMPOSITIONS | 2020-05-07 |
20200138824 | TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESELECTED FOR HAVING A PIK3CA MUTATION IN THE CTDNA | 2020-05-07 |
20200138825 | METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR | 2020-05-07 |
20200138826 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | 2020-05-07 |
20200138827 | SMALL MOLECULE MODULATORS OF HUMAN STING | 2020-05-07 |
20200138828 | Anti-thrombotic Agents and Methods of Use Thereof | 2020-05-07 |
20200138829 | METHODS OF CANCER TREATMENT | 2020-05-07 |
20200138830 | ENHANCING GABA'S ABILITY TO MODULATE IMMUNE RESPONSES | 2020-05-07 |
20200138831 | OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER | 2020-05-07 |
20200138832 | COMPOUNDS AND PRODRUGS THEREOF FOR THE TREATMENT OF OPHTHALMIC DISEASE | 2020-05-07 |
20200138833 | CHEMOPREVENTION OF COLORECTAL CANCER | 2020-05-07 |
20200138834 | COMPOSITION, FOR OSTEOARTHRITIS TREATMENT, COMPRISING HYDROPHILIZED SULFASALAZINE AND HYALURONIC ACID AND METHOD FOR PREPARING SAME | 2020-05-07 |
20200138835 | FORMULATIONS OF BRINCIDOFOVIR | 2020-05-07 |
20200138836 | HMOS BLENDS FOR USE IN INFANTS OR YOUNG CHILDREN FOR HEALTH PURPOSES | 2020-05-07 |
20200138837 | COMPOSITION FOR INHIBITING IMMUNE CELL PROLIFERATION COMPRISING SIALYLLACTOSE OR DERIVATIVE THEREOF AND METHOD THEREOF | 2020-05-07 |
20200138838 | COMPOSITION COMPRISING HMSS/HMOS AND USE THEREOF | 2020-05-07 |
20200138839 | GLUCOSE INFUSION SOLUTION COMPOSITION | 2020-05-07 |
20200138840 | PHARMACEUTICAL COMPOSITION AND TUMOR IMMUNOACTIVITY PROMOTER | 2020-05-07 |
20200138841 | NOVEL USE | 2020-05-07 |
20200138842 | USE OF BIOSURFACTANT | 2020-05-07 |